Drug Type Small molecule drug |
Synonyms PF 592379, PF-000592379 |
Target |
Action agonists |
Mechanism D3 receptor agonists(Dopamine D3 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H21N3O |
InChIKeyDFTCYTDJDXZFSK-JQWIXIFHSA-N |
CAS Registry710655-15-5 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | PF-592379 | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoarthritis | Phase 2 | United States | 01 Jun 2007 | |
| Pain | Phase 2 | United States | 01 Jun 2007 | |
| Synovitis of knee | Phase 2 | United States | 01 Jun 2007 | |
| Erectile Dysfunction | Phase 2 | Norway | 01 Jan 2006 | |
| Erectile Dysfunction | Phase 2 | United Kingdom | 01 Jan 2006 |





